Horizon Pharma To Buy Hyperion Therapeutics For $1.1B
Irish drug company Horizon Pharma PLC said Monday it has agreed to buy California biotech Hyperion Therapeutics Inc. for $1.1 billion cash, adding revenue-generating orphan disease products to its portfolio, continuing...To view the full article, register now.
Already a subscriber? Click here to view full article